|
1
|
|
|
|
Podcast 126: Placebos and Medical ‘Meaning’
|
|
|
3 位听众
|
|
2
|
|
|
|
Podcast 118: Opioid prescribing patterns and accidental overdoses
|
|
|
3 位听众
|
|
3
|
|
|
|
Podcast 120: Pass the salt!
|
|
|
3 位听众
|
|
4
|
|
|
|
Podcast 105: NSAIDs revisited
|
|
|
3 位听众
|
|
5
|
|
|
|
Podcast 76: On saying “No” to patients’ requests.
|
|
|
3 位听众
|
|
不想看到广告？马上升级
|
|
6
|
|
|
|
Podcast 103: eGFR and cardiovascular risk assessment
|
|
|
3 位听众
|
|
7
|
|
|
|
Podcast 75: Which regimen for hypertension?
|
|
|
3 位听众
|
|
8
|
|
|
|
Podcast 44: Harlan Krumholz on new door-to-balloon-time findings.
|
|
|
3 位听众
|
|
9
|
|
|
|
Podcast 95: What if hypertensive patients titrated their own drug dosages?
|
|
|
2 位听众
|
|
10
|
|
|
|
Podcast 99: Blacks’ higher rate of stent thrombosis apparently has a genetic basis.
|
|
|
2 位听众
|
|
11
|
|
|
|
Podcast 80: Bisphosphonates and atypical hip fractures — how large is the risk?
|
|
|
2 位听众
|
|
12
|
|
|
|
Podcast 43: An interview with Martha Gulati on her research into the cardiovascular risks faced by symptomatic women who have normal angiograms.
|
|
|
2 位听众
|
|
13
|
|
|
|
Podcast 82: Checklists save lives — lots of lives. Becoming a clinical automaton.
|
|
|
2 位听众
|
|
14
|
|
|
|
Podcast 77: We revisit a conversation on treating community-acquired pneumonia according to the guidelines (and we’ve got current news).
|
|
|
2 位听众
|
|
15
|
|
|
|
Podcast 45: Prof. Martin Dennis discusses new findings discouraging the use of compression stockings after stroke
|
|
|
2 位听众
|
|
16
|
|
|
|
Podcast 154: Treating heart failure’s hypercoagulable state — warfarin or aspirin?
|
|
|
2 位听众
|
|
17
|
|
|
|
Podcast 121: NSAIDs Unsafe at Any Dose after MI
|
|
|
2 位听众
|
|
18
|
|
|
|
Podcast 122: Most newer antiepileptics apparently safer in early pregnancy — but not all.
|
|
|
2 位听众
|
|
19
|
|
|
|
Podcast 124: Getting more accuracy into blood pressure measurements
|
|
|
2 位听众
|
|
20
|
|
|
|
Podcast 98: Leafy green vegetables apparently lower one’s risks for type 2 diabetes
|
|
|
2 位听众
|
|
21
|
|
|
|
Podcast 123: Calcium’s benefits seem to peak out at about 800 mg daily
|
|
|
2 位听众
|
|
22
|
|
|
|
Podcast 106: The barbershop and hypertension — a little off the top
|
|
|
2 位听众
|
|
23
|
|
|
|
Podcast 97: What happens when vena cava filters break?
|
|
|
2 位听众
|
|
24
|
|
|
|
Podcast 68: Change your approach to pharyngitis in adolescents and young adults.
|
|
|
2 位听众
|
|
25
|
|
|
|
Podcast 78: Just what are “comparative effectiveness” studies anyway?
|
|
|
2 位听众
|
|
不想看到广告？马上升级
|
|
26
|
|
|
|
Podcast 72: A conversation about two new drugs for multiple sclerosis.
|
|
|
2 位听众
|
|
27
|
|
|
|
Podcast 74: How two SSRIs apparently interfere with tamoxifen therapy.
|
|
|
2 位听众
|
|
28
|
|
|
|
Podcast 49: Three RASS Study researchers discuss their findings on the lack of benefit of renin-angiotensin blockade in the primary prevention of diabetic nephropathy in Type 1 diabetes.
|
|
|
2 位听众
|
|
29
|
|
|
|
Podcast 54: A conversation with Aaron Caughey, whose analysis of the literature shows that elective induction of labor does not, contrary to dogma, increase the risk of cesarean delivery.
|
|
|
2 位听众
|
|
30
|
|
|
|
Podcast 134: How (and why) surveillance in Barrett’s esophagus should change
|
|
|
1 位听众
|
|
31
|
|
|
|
Podcast 160: The Marathon bombing — lessons learned
|
|
|
1 位听众
|
|
32
|
|
|
|
Podcast 104: Reassurance on clopidogrel and omeprazole.
|
|
|
1 位听众
|
|
33
|
|
|
|
Podcast 63: A conversation about the adverse cardiometabolic effects of second-generation antipsychotic drugs in young patients with Christoph Correll
|
|
|
1 位听众
|
|
34
|
|
|
|
Podcast 85: B vitamins lower homocysteine levels, so why don’t they retard the progression of diabetic nephropathy?
|
|
|
1 位听众
|
|
35
|
|
|
|
Podcast 66: Niacin versus ezetimibe in the face of high cardiovascular risk — a conversation with the ARBITER 6-HALTS trialist Allen Taylor
|
|
|
1 位听众
|
|
36
|
|
|
|
Podcast 87: After this week’s news, we reprise an interview from last December on pharyngitis in adolescents and young adults.
|
|
|
1 位听众
|
|
37
|
|
|
|
Podcast 150: Depression (and antidepressant use) after stroke or TIA
|
|
|
1 位听众
|
|
38
|
|
|
|
Podcast 146: Cognitive impairment in primary care — screen or not?
|
|
|
1 位听众
|
|
39
|
|
|
|
Podcast 164: Talking about death
|
|
|
1 位听众
|
|
40
|
|
|
|
Podcast 167 — The polypill: adherence at last?
|
|
|
1 位听众
|
|
41
|
|
|
|
Podcast 152: Gum disease and atherosclerosis — evidence for an association, but not for a cause-and-effect
|
|
|
1 位听众
|
|
42
|
|
|
|
Podcast 131: Measuring the effect of the rotavirus vaccine program on kids in the U.S.
|
|
|
1 位听众
|
|
43
|
|
|
|
Podcast 151: Most people above age 10 have at least some cross-reactive antibodies to variant influenza
|
|
|
1 位听众
|
|
44
|
|
|
|
Podcast 119: Calcium supplements & risk
|
|
|
1 位听众
|
|
45
|
|
|
|
Podcast 149: High levels of white rice consumption seem linked to higher risks for type 2 diabetes
|
|
|
1 位听众
|
|
|
|
46
|
|
|
|
Podcast 141: Clinically apparent atrial fibrillation increases stroke risk; does subclinical afib do the same?
|
|
|
1 位听众
|
|
47
|
|
|
|
Podcast 132: In discussing a child’s overweight with parents, words matter
|
|
|
1 位听众
|
|
48
|
|
|
|
Podcast 155: What’s wrong with U.S. healthcare and what will save it?
|
|
|
1 位听众
|
|
49
|
|
|
|
Podcast 115: Talking about the real-world use of dabigatran with Drs. Elaine Hylek and Samuel Goldhaber
|
|
|
1 位听众
|
|
50
|
|
|
|
Hot flashes and escitalopram
|
|
|
1 位听众
|
